Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis

Current Allergy and Asthma Reports

Volumn 4, Issue 6, 2004, Pages 478-485

  Gillespie, M Boyd ^a   Osguthorpe, J David ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BECLOMETASONE; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; KETOLIDE; MONTELUKAST; MUCOPIRICIN; PLACEBO; PREDNISONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ROXITHROMYCIN; UNCLASSIFIED DRUG; XYLOMETAZOLINE; ZAFIRLUKAST; ZILEUTON;

CLINICAL FEATURE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RECEPTOR BINDING; DYSPEPSIA; FACE PAIN; HEADACHE; HUMAN; NOSE OBSTRUCTION; NOSE POLYP; REVIEW; RHINOSINUSITIS; SIDE EFFECT; TREATMENT PLANNING;

EID: 9744250236     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-004-0015-3     Document Type: Review

References (69)

1. Benninger M, Ferguson B, Hadley J, et al.: Adult-chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003, 129 (Suppl 3):S1-S32.
2. Larsen P, Tos M: Origin of nasal polyps. Laryngoscope 2004, 114:710-719.
3. Bachert C, Hormann K, Mosges R, et al.: An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003, 58:176-191.
4. Kowalski ML: Rhinosinusitis and nasal polyposis in aspirin-sensitive and aspirin-tolerant patients: Are they different? Thorax 2000, 55 (Suppl2):S84-S86.
5. Jahnsen FL, Haraldsen G, Aanesen JP, et al.: Eosinophil infiltration is related to increased expression of vascular cell adhesion molecule-1 in nasal polyps. Am J Respir Cell Mol Biol 1995, 12:624-632.
6. Simon HU, Youseti S, Schranz C, et al.: Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997, 158:3902-3908.
7. Rhyoo C, Sanders SP, Leopold DA, Droud O: Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol 1999, 103:395-400.
8. Nonoyama T, Harada T, Shinogi J, et al.: Immunohistochemical localization of cytokines and cell adhesion molecules in maxillary sinus mucosa in chronic sinusitis. Auris Nasus Larynx 2000, 27:51-58.
9. Bachert C, Wagenmann M, Rudock C, et al.: The role of cytokines in infectious sinusitis and nasal polyposis. Allergy 1998, 53:2-13.
10. Malekzadeh S, McGuire J: The new histologic classification of chronic rhinosinusitis. Curr Allergy Asthma Rep 2003, 3: 21-226.
11. Doyle PW, Woodham JD: Evaluation of the microbiology of chronic ethmoid sinusitis. J Clin Microbiol 1991, 29: 396-2400.
12. Hoyt WH: Bacterial patterns found in surgery patients with chronic sinusitis. J Am Osteopath Assoc 1992, 92:209-212.
13. Hsu J, Lanza DC, Kennedy DW: Antimicrobial resistance in bacterial chronic sinusitis. Am J Rhinol 1998, 12:243-248.
14. Biel MA, Brown CA, Levinson RM, et al.: Evaluation of the microbiology of chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 1998, 107:942-945.
15. Brook I, Frazier EH: Correlation between microbiology and previous sinus surgery in patients with chronic maxillary sinusitis. Ann Otol Rhinol Laryngol 2001, 110:148-151.
16. Jiang RS, Lin JF, Hsu CY: Correlation between bacteriology of the middle meatus and the ethmoid sinus in chronic sinusitis. J Laryngol Otol 2002, 116:443-446.
17. Finegold SM, Flynn MJ, Rose FV, et al.: Bacteriologic findings associated with chronic bacterial maxillary sinusitis in adults. Clin Infect Dis 2002, 35:428-433.
18. Gordts F, Halewyck S, Pierard D, et al.: Microbiology of the middle meatus: a comparison between normal adults and children. J Laryngol Otol 2000, 114:184-188.
19. Osguthorpe JD: Adult rhinosinusits: diagnosis and management. Am Fam Physician 2001, 63:69-76.
20. Anon J, Jacobs M, Poole M, et al.: Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004, 130 (1 Suppl):1-45.
21. Namyslowski G, Misiolek M, Czecior E, et al.: Comparison of the efficacy and tolerability of amoxicillin/clavulanic acid 875 mg. b.i.d. with cefuroxime 500 mg b.i.d. in the treatment of chronic and acute exacerbation of chronic sinusitis in adults. J Chemother 2002, 14:508-517.
22. Legent F, Bordure P, Beauvillain C, Berche P: A double-blind comparison of ciprofloxacin and amoxicillin/ clavulanic acid in the treatment of chronic sinusitis. Chemotherapy 1994, 40 (Suppl1):8-15.
23. Dellamonica P, Choutet P, Lejeune JM, et al.: Efficacy and tolerance of cefotiam hexetil in the super-infected chronic sinusitis. A randomized, double-blind study in comparison with cefixime. Ann Otolaryngol Chir Cervicofac 1994, 111:217-222.
24. Sinus & Allergy Health Partnership: Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2000, 123:1-4.
25. Norlander T, Bronnegard M, Stierna P: The relationship of nasal polyps, infection, and inflammation. Am J Rhinol 1999, 13:349-355.
26. Bernstein J, Ballow M, Schlievert P, et al.: A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2003, 17: 21-326.
27. Bachert C, Gevaert P, van Cauwenberge P: Staphylococcus aureus superantigens and airway disease. Curr Allergy Asthma Rep 2002, 2:252-258.
28. Schubert MS: A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 2001, 87:181-188.
29. Iino Y, Sasaki Y, Kojima C, Miyazawa T: Effect of macrolides on the expression of HLA-DR and costimulatory molecules on antigen-presenting cells in nasal polyps. Ann Otol Rhinol Laryngol 2001, 110:457-463.
30. Cervin A: The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol 2001, 121:83-92.
31. Garey KW, Alwani A, Danziger LH, Rubinstein I: Tissue reparative effects of macrolide antibiotics in chronic inflammatory sino-pulmonary diseases. Chest 2003, 123:261-265.
32. Post JC: Direct evidence of bacterial biofilms in otitis media. Laryngoscope 2001, 111:2083-2094.
33. Damm M, Jungehulsing M, Eckel HE, et al.: Effects of systemic steroid treatment in chronic polypoid rhinosinusitis evaluated with magnetic resonance imaging. Otolaryngol Head Neck Surg 1999, 120:517-523.
34. Schleimer R: Glucocorticosteroids: their mechanisms of activation and use in allergic diseases. In Allergy: Principals and Practice, edn 4. Edited by Middleton EJ, Reed CE, Ellis EF, et al. St. Louis: Mosby-Year Book; 1993:893-925.
35. Cox G, Ohtoshi T, Vancheri C, et al.: Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991, 4: 25-531.
36. Senior B, Kennedy D, Tanabodee J, et al.: Long-term results of functional endoscopic sinus surgery. Laryngoscope 1998, 108:151-157.
37. Allen DB, Meltzer EO, Lemanske RF, et al.: No growth suppression in children treated with the maximum recommended dose of fluticasone propionate aqueous nasal spray for one year. Allergy Asthma Proc 2002, 23:407-413.
38. Skoner DP, Gentile D, Angelini B, et al.: The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis. Ann Allergy Asthma Immunol 2003, 90: 6-62.
39. Dolor RJ, Witsell DL, Hellkamp AS, et al.: Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. JAMA 2001, 286:3097-3105.
40. Jankowski R, Schrewelius C, Bonfils P, et al.: Efficacy and tolerability of budesonide aqueous nasal spray treatment in patients with nasal polyps. Arch Otolaryngol Head Neck Surg 2001, 127:447-452.
41. Filiaci F, Passali D, Puxeddu R, Schrewelius C: A randomized, controlled trial showing efficacy of once daily intranasal budesonide in nasal polyposis. Rhinology 2000, 38:185-190.
42. Keith P, Nieminen J, Hollingworth K, Dolovich J: Efficacy and tolerability of fluticasone propionate nasal drops 400 micrograms once daily compared with placebo for the treatment of bilateral polyposis in adults. Clin Exp Allergy 2000, 30:1460-1468.
43. Badia L, Lund V: Topical corticosteroids in nasal polyposis. Drugs 2001, 61:573-578.
44. El Naggar M, Kale S, Aldren C, Martin F: Effect of beconase nasal spray on olfactory function in post-nasal polypectomy patients: a prospective controlled trial. J Laryngol Otol 1995, 109:941-944.
45. Holmstrom M: Clinical performance of fluticasone propionate nasal drops. Allergy 1999, 54:21-25.
46. Karlsson G, Rundcrantz H: A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982, 20:144-148.
47. Drettner B, Ebbesen A, Nilsson M: Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982, 20: 49-158.
48. Bross-Soriano D, Arrieta-Gomez J, Prado-Calleros H: Infections after endoscopic polypectomy using nasal steroids. Otolaryngol Head Neck Surg 2004, 130:319-322.
49. Benninger M, Hadley J, Osguthorpe JD, et al.: Techniques of intranasal steroid use. Otolaryngol Head Neck Surg 2004, 130:5-24.
50. Bonfils P, Mores J, Halimi P, Avan P: Corticosteroid treatment in nasal polyposis with a three-year follow-up period. Laryngoscope 2003, 113:683-687.
51. Parnes SM: The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg 2003, 11:184-191.
52. Ragab S, Parikh A, Darby YC, Scadding GK: An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001, 31: 385-1391.
53. Parnes SM, Chuma AV: Acute effects of antileukotrienes on sinusitis and sinonasal polyposis. Ear Nose Throat J 1999, 79:18-25.
54. Grundmann T, Töpfner M: Leukotrienrezeptorantagonisten zur rezidivprophylaxe bei der ASS-assocziierten polyposiserste klinische ergebnisse zur wirkung auf entzundliche gewebeprozesse. Laryngol Rhinol Otol 2001, 80:576-582.
55. Braun JJ, Alabert JP, Michel FB, et al.: Adjunct effect of loratidine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy 1997, 52:650-655.
56. Haye R, Aanesen JP, Burtin B, et al.: The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 1998, 112:1042-1046.
57. Berrettini S, Carabelli A, Sellari-Franceschini S, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy 1999, 54:242-248.
58. Yariktas M, Doner F, Demirci M: Rhinosinusitis among the patients with perennial or seasonal allergic rhinitis. Asian Pac J Allergy Immunol 2003, 21:75-78.
59. Ramadan HH, Fornelli R, Ortiz AO, Rodman S: Correlation of allergy and severity of sinus disease. Am J Rhinol 1999, 13: 45-347.
60. Bachmann G, Hommel G, Michel O: Effect of irrigation of the nose with isotonic salt solution on adult patients with chronic paranasal sinus disease. Eur Arch Otolaryngol 2000, 257: 37-541.
61. Rabago D, Zgierska A, Mundt M, et al.: Efficacy of daily hypertonic saline irrigation among patients with sinusitis: a randomized controlled trial. J Fam Prac 2002, 51: 049-1055.
62. Davidson T, Murphy C, Mitchell M, et al.: Management of chronic sinusitis in cystic fibrosis. Laryngoscope 1995, 105:354-358.
63. Poinkau J, Sherris D, Kita H, Kern E: Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 2003, 110:862-866.
64. Ricchetti A, Landis B, Maffioli A, et al.: Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002, 116:261-263.
65. Norès J-M, Avan P, Bonfils P: Medical management of nasal polyposis: a study in a series of 152 consecutive patients. Rhinology 2003, 41:97-102.
66. Osguthorpe JD: Surgical outcomes in rhinosinusitis: what we know. Otolaryngol Head Neck Surg 1999, 120:451-453.
67. Dursun E, Korkmaz H, Eryilmaz A, et al.: Clinical predictors of long-term success after endoscopic sinus surgery. Otolaryngol Head Neck Surg 2003, 129:526-531.
68. Blomqvist EH, Lundblad L, Änggard A, et al.: A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 2001, 107:224-228.
69. Garrel R, Gardiner Q, Khudjadze M, et al.: Endoscopic surgical treatment of sinonasal polyposis-medium term outcomes (mean follow-up of 5 years). Rhinology 2003, 41:91-96.